This inventor holds 1 USPTO granted patent. Top assignee: Eli Lilly and Company. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Brian Spencer Jones: Innovator in Pharmaceutical Science
Introduction
Brian Spencer Jones is a notable inventor based in Indianapolis, IN (US). He has made significant contributions to the field of pharmaceutical science, particularly in the development of treatments for autoimmune diseases. His work has the potential to improve the quality of life for many patients suffering from chronic conditions.
Latest Patents
Brian Spencer Jones holds 1 patent related to IL-17A inhibitors. This invention provides certain difluorocyclohexyl-imidazopyridazinyl-imidazolidinone compounds of formula II as IL-17A inhibitors. The pharmaceutical compositions derived from this invention are aimed at treating symptoms of psoriasis, rheumatoid arthritis, and multiple sclerosis.
Career Highlights
Brian is currently employed at Eli Lilly and Company, a leading global pharmaceutical company. His role involves research and development of innovative therapies that address unmet medical needs. His expertise in the field has positioned him as a valuable asset to his team and the company.
Collaborations
Brian has collaborated with several talented individuals in his field, including David Andrew Coates and Kwame Frimpong. These collaborations have fostered a creative environment that encourages the exchange of ideas and advancements in pharmaceutical research.
Conclusion
Brian Spencer Jones is a dedicated inventor whose work in IL-17A inhibitors showcases his commitment to advancing medical science. His contributions have the potential to make a significant impact on the treatment of autoimmune diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile